Acquisition of Reagents for Tumor Markers to be Processed on the Maglumi X3 Equipment

By: National Institute of Nuclear Medicine - Inamen๐Ÿ“ BoliviaOpen

Key Information

ReferenceGB-26-0902-03-1708154-1-1
DeadlineNov 17, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryBolivia
AddressBolivia
PublishedNov 11, 2026

Description

Acquisition of Reagents for Tumor Markers to be Processed on the Maglumi X3 Equipment

Full details are available after unlocking this tender.